Highlights AstraZeneca PLC

Stocks

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:08 2026-07-17 am EDT			5-day change	1st Jan Change
12,594.00 ^GBX	-0.27%		-1.87%	-8.67%

Jul. 17	Nordic stocks in North America - Astra Zeneca fell 0.3%	FW
Jul. 16	Illumina, Inc., Formation Bio, Astrazeneca, Merck, and Eli Lilly and Company Expand Billion Cell Atlas Alliance with New Ai Drug Developers	CI

Highlights

Jul. 16	Illumina, Inc., Formation Bio, Astrazeneca, Merck, and Eli Lilly and Company Expand Billion Cell Atlas Alliance with New Ai Drug Developers	CI
Jul. 14	AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal	MT
Jul. 14	AstraZeneca Enters Exclusive Global License Agreement Fornovel Oral EGFR Inhibitor Zegfrovy for Lung Cancer with Dizal Pharmaceutical	CI
Jul. 14	AstraZeneca buys worldwide rights to cancer drug for USD1.5 billion	AN
Jul. 14	AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion	DJ
Jul. 14	AstraZeneca Signs Licensing Deal With Dizal for Lung Cancer Treatment	MT
Jul. 14	AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical	RE
Jul. 13	Berenberg Says Market Reaction to AstraZeneca's Wainua Late-stage Trial Miss 'Overdone'; Price Target, Estimates Revised	MT
Jul. 09	US Appeals Court Upholds Ruling in Favor of AstraZeneca in Patent Case Against Pfizer Unit	MT
Jul. 09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
Jul. 09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
Jul. 09	Top Midday Decliners	MT
Jul. 09	BofA Notes AstraZeneca's 'Surprise' Wainua Late-stage Trial Miss; Buy Rating Retained	MT
Jul. 09	AstraZeneca Shares Slide After Wainua Treatment Fails Heart Disease Trial	DJ
Jul. 09	AstraZeneca Shares Slide After Heart Drug Trial Misses Primary Endpoint	MT
Jul. 09	AstraZeneca shares fall 9% as cardiovascular drug Wainua fails test	AN
Jul. 09	AstraZeneca tumbles, Schott Pharma raises its ambitions
Jul. 09	AstraZeneca's Wainua fails key heart disease trial, shares tumble	RE
Jul. 09	UK Life Sciences Hits GBP3 Billion Investment Milestone	MT
Jul. 08	UK Regulator in Talks with AstraZeneca, Daiichi Sankyo for Enhertu Pricing	MT
Jul. 08	AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports	RE
Jul. 08	AstraZeneca Acquires Rights for Potential Chinese Respiratory Disease Drug for up to $2.1 Billion	MT
Jul. 08	UK stocks-factors to watch on July 8	RE
Jul. 08	AstraZeneca Secures Exclusive Rights Outside China for Inhaled PDE3/4 Inhibitor	MT
Jul. 07	AstraZeneca Enters Multi-Year Genomics Agreement With Helix for Drug Discovery Research	MT